AI Radiology

Hyperfine Swoop vs Qure.ai
Qure.ai reads X-rays and head CTs while Hyperfine builds a brain scanner, so no purchase puts them head to head. Qure.ai sells to hospitals and TB screening programs. Its qER head CT triage was cleared in 2020 (K200921), qXR-LN covers lung nodules on adult frontal chest radiographs, and Qure.ai reports a WHO endorsement from 2021 for TB screening. An independent 12-product evaluation put qXR v3 at 95.5% sensitivity and 48.7% specificity at one threshold. Hyperfine sells to ICUs and resource-limited hospitals. A Malawi case review praises Swoop for bedside brain imaging where a fixed MRI suite is out of reach, and a research paper estimates about $50,000 per system. Qure.ai publishes no price, and Hyperfine's 10-K summary describes ownership plus an annual service agreement.
Radiology · Reviewed November 2, 2026
On this page

Hyperfine Swoop
by Hyperfine
Portable 0.064T brain MRI (Swoop) with Optive AI image reconstruction. Also BrainInsight AI brain morphometry.

Qure.ai
by Qure.ai
AI for chest X-ray (qXR), head CT (qER) and lung nodule CT, with TB screening. The homepage cites sites across 107 countries.
When to pick each one
Hyperfine Swoop
- Malawi review praises bedside brain imaging
- Older research paper estimates about $50,000 per system
Qure.ai
- qER head CT triage, 510(k) cleared in 2020
- Qure.ai reports a WHO endorsement for TB screening, 2021
- CE Class IIb under MDR for qXR v4.0 and qCT
Score
Each row shows points earned of points available under the published rubric.
Hyperfine Swoop
Qure.ai
| Dimension | Hyperfine Swoop | Qure.ai | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 12.7 / 18.2 | 12.7 / 18.2 | 0 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 6 / 12 | 8.4 / 12 | -2.4 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Hyperfine Swoop
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | Not stated | Not stated | No public price. Per the FY2025 10-K summary, systems are owned, with an annual software, service and support agreement after a one-year warranty on 36- or 60-month terms. Dollar amounts were not found. |
Qure.ai
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | Not stated | Not stated | No public price. Grant funding is not stated on Qure pages. |
Evidence
Hyperfine Swoop
FDA decisions
K262622 (opens in new tab)510(k)2026-08-19
Swoop
K253489 (opens in new tab)510(k)2025-12-12
Swoop
K250236 (opens in new tab)510(k)2025-05-30
Swoop (V2)
K251276 (opens in new tab)510(k)2025-05-21
Swoop
K240944 (opens in new tab)510(k)2024-07-16
Swoop
Show 12 more
K232760 (opens in new tab)510(k)2023-10-06
Swoop
K230208 (opens in new tab)510(k)2023-02-22
Swoop
K223268 (opens in new tab)510(k)2022-12-16
BrainInsight
K223247 (opens in new tab)510(k)2022-12-06
Swoop
K221923 (opens in new tab)510(k)2022-07-28
Swoop
K220815 (opens in new tab)510(k)2022-07-19
BrainInsight
K221393 (opens in new tab)510(k)2022-06-10
Swoop
K212456 (opens in new tab)510(k)2021-11-17
Swoop
K211818 (opens in new tab)510(k)2021-07-07
Swoop
K202414 (opens in new tab)510(k)2021-01-07
BrainInsight
K201722 (opens in new tab)510(k)2020-08-11
Hyperfine POC MRI
K192002 (opens in new tab)510(k)2020-02-06
Lucy POC MRI
Peer-reviewed
4 PubMed records name Hyperfine Swoop.
- Super resolution using sparse sampling at portable ultra-low field MR. (opens in new tab)
- Tips and challenges for clinical use and interpretation of low field portable MRI in neuroimaging. (opens in new tab)
- Case-based review of low-field MRI in resource-constrained settings: a clinical perspective from Malawi. (opens in new tab)
Qure.ai
FDA decisions
K261517 (opens in new tab)510(k)2026-09-14
qCT Lung v1.0
K251934 (opens in new tab)510(k)2026-01-16
qXR-Detect
K251610 (opens in new tab)510(k)2025-09-08
qER-CTA v1.0
K240740 (opens in new tab)510(k)2024-08-16
qCT LN Quant
K231805 (opens in new tab)510(k)2023-12-22
qXR-LN
Show 5 more
K231149 (opens in new tab)510(k)2023-09-22
qXR-CTR
K230899 (opens in new tab)510(k)2023-08-22
qXR-PTX-PE
K212690 (opens in new tab)510(k)2021-12-21
qXR-BT
K211222 (opens in new tab)510(k)2021-07-30
qER-Quant
K200921 (opens in new tab)510(k)2020-06-17
qER
Peer-reviewed
4 PubMed records name Qure.ai.
- Radiograph accelerated detection and identification of cancer in the lung (RADICAL): a mixed methods study to assess the clinical effectiveness and acceptability of Qure.ai artificial intelligence software to prioritise chest X-ray (CXR) interpretation. (opens in new tab)
- Revolutionizing Healthcare: Qure.AI's Innovations in Medical Diagnosis and Treatment. (opens in new tab)
- A Case Series From a Multicentric Study: Can Artificial Intelligence (AI)-Enabled Chest X-Ray Assist in the Incidental Detection of Early-Stage Lung Cancers? (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Hyperfine Swoop | Qure.ai |
|---|---|---|
| Free tier | No / unverified | No / unverified |
| HIPAA | No / unverified | No / unverified |
| SOC 2 Type II | No / unverified | No / unverified |
| EHR integrations | Not stated | Not stated |
| Founded | Not stated | Not stated |
| HQ | US | IN |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.
See all radiology